Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 145,369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Shwachman-Diamond Syndrome, SDS, IBMF, Congenital Neutropenia, Heme Malignancy, Shwachman Syndrome, Inherited Bone Marrow Failure, Exocrine Pancreatic Insufficiency, WHIM, ELANE, SBDS Gene Mutation, EFL1 Gene Mutation, DNAJC21 Gene Mutation, SRP54 Gene Mutation, Inherited Cancer Syndrome, Inherited Cancer-Predisposing Syndrome, Neutropenia, Severe Chronic, Neutropenia Other, Neutropenia Chronic Benign, Ribosome Alteration, Ribosomopathy, Immune Deficiency, Inherited BMF Syndrome, Inherited Immunodeficiency Diseases, Cognitive Delay, Mild, Myelodysplastic Syndromes, Pancytopenia
Interventions: Not listed
Lead sponsor: Shwachman-Diamond Syndrome Alliance Inc; Other
Eligibility: Not listed
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2088
U.S. locations: 1
States / cities: Woburn, Massachusetts

Conditions: Gynecologic Cancer, Gynecologic Disease, Gynecological Surgery, Uterine Cancer
Interventions: Uterine Lavage; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Ovarian Cancer
Interventions: Topotecan and VP16; Drug
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Epilepsy
Interventions: pregabalin; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 34
States / cities: Phoenix, Arizona • Fayetteville, Arkansas • Fullerton, California + 29 more

Conditions: Hypertension
Interventions: Aliskiren, Hydrochlorothiazide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 55 Years and older
Enrollment: 451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Foot and Ankle Disorders, Ankle Fusion, Osteotomy
Interventions: BioBurst Fluid, Burst Allograft; Device
Lead sponsor: Burst Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Viral Infection, Hematopoietic Stem Cell Transplantation (HSCT), Primary Immunodeficiency Disorders (PID)
Interventions: Norovirus -specific T-cell (NST) therapy; Biological
Lead sponsor: Children's National Research Institute; Other
Eligibility: 3 Months to 80 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Bethesda, Maryland

Conditions: Contact Lens Discomfort, Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: Bruder Moist Heat Compress, Washcloth; Device · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Human Immunodeficiency Virus, HIV Infections
Interventions: CHIMES Intervention, Standard of Care; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 29 Years · Male only
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Obesity
Interventions: Transcutaneous electrical nerve stimulation (TENS); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Progressive Supranuclear Palsy
Interventions: Fresh Frozen Plasma; Biological
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 85 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cannabis Use Disorder
Interventions: Motivational Enhancement Therapy plus Ecological Momentary Intervention, Enhanced Usual Care; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 26 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases
Interventions: Brentuximab Vedotin, CHEP; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 4
States / cities: Hollywood, Florida • Boston, Massachusetts • Chapel Hill, North Carolina

Conditions: Infertility
Interventions: Healing Touch, Desensitization Therapy; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Nasal Obstruction
Interventions: Microdebrider-Assisted Inferior Turbinoplasty (MAIT), Submucous Resection with non powered instrument; Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Myopia
Interventions: comfilcon A, samfilcon A; Device
Lead sponsor: CooperVision, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Whittier, California • Medina, Minnesota

Conditions: Short Bowel Syndrome
Interventions: Crofelemer Oral Product; Drug
Lead sponsor: Jessica Sosio; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obstetric Complication, GYN Disorders
Interventions: Obstetrics and Gynecology clinical applications for ultrasound diagnostic systems; Device
Lead sponsor: EchoNous Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Redmond, Washington

Conditions: Hidradenitis Suppurativa
Interventions: 23.4% Hypertonic saline; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carotid Artery Stenosis
Interventions: Magnetic resonance imaging, Neuropsychological testing; Other · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 40 Years and older
Enrollment: 207 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Sickle Cell Disease
Interventions: GMI-1070; Drug
Lead sponsor: GlycoMimetics Incorporated; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Oakland, California • Sacramento, California • Durham, North Carolina

Conditions: Mild Traumatic Brain Injury
Interventions: TecTraum device; Device
Lead sponsor: TecTraum Inc.; Industry
Eligibility: 12 Years to 21 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 5
States / cities: Ann Arbor, Michigan • Akron, Ohio • Boardman, Ohio + 2 more

Conditions: Stroke
Interventions: Hip exoskeleton, Baseline; Device · Other
Lead sponsor: Georgia Institute of Technology; Other
Eligibility: 18 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Fecal Incontinence
Interventions: InterStim Sacral Nerve Stimulation Therapy; Device
Lead sponsor: MedtronicNeuro; Industry
Eligibility: 18 Years and older
Enrollment: 285 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2011
U.S. locations: 12
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 9 more

Search by objective public record fields.

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

Clinical Benefit of Topoisomerase Downregulation

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

Burst Biologics Foot and Ankle Registry

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers

Cross-disciplinary HIV Integrated Mental Health Support Intervention

Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity

Young Plasma Transfusions for Progressive Supranuclear Palsy

Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Stress Reduction During In Vitro Fertilization

Trial Comparing Microdebrider-Assisted Inferior Turbinoplasty (MAIT) vs Submucous Resection (SMR)

Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses

Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome

OB-GYN Clinical Validation Study

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

Neuroimaging Correlates of Memory Decline Following Carotid Interventions

Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease

Pro-2-Cool Device Clinical Study

Adaptive Hip Exoskeleton for Stroke Gait Enhancement

Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence